The number of excised lymph nodes is associated with survival of melanoma patients with lymph nodemetastasis

Annals of Oncology

Volumn 25, Issue 1, 2014, Pages 240-246

  Rossi, C R ^a,b   Mozzillo, N ^c   Maurichi, A ^d   Pasquali, S ^b   Quaglino, P ^e   Borgognoni, L ^f   Solari, N ^g   Piazzalunga, D ^h   Mascheroni, L ⁱ   Giudice, G ^j   Mocellin, S ^b   Patuzzo, R ^d   Caraco C ^c   Ribero, S ^e   Marone, U ^c   Santinami, M ^d  

^a VENETO INSTITUTE OF ONCOLOGY IOV IRCCS   (Italy)

^b UNIVERSITY OF PADOVA   (Italy)

^c NATIONAL CANCER INSTITUTE   (Italy)

^d NATIONAL CANCER INSTITUTE   (Italy)

^e UNIVERSITY OF TURIN   (Italy)

^f SANTA MARIA ANNUNZIATA HOSPITAL   (Italy)

^g UNIVERSITY OF GENOA   (Italy)

^h Division of Anaesthesia   (Italy)

ⁱ HUMANITAS CLINICAL AND RESEARCH CENTER   (Italy)

^j UNIVERSITY OF BARI   (Italy)

more..

Author keywords

Lymph node; Lymph node dissection; Melanoma; Prognosis

Indexed keywords

ADULT; AGE; AGED; ARTICLE; AXILLARY LYMPH NODE; CANCER PROGNOSIS; CANCER SPECIFIC SURVIVAL; CANCER STAGING; CERVICAL LYMPH NODE; CUTANEOUS MELANOMA; DISEASE ASSOCIATION; FEMALE; HUMAN; HUMAN TISSUE; ILIOINGUINAL LYMPH NODE; INGUINAL LYMPH NODE; LYMPH NODE BIOPSY; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MICROMETASTASIS; NUMBER OF EXCISED LYMPH NODE; ONCOLOGICAL PARAMETERS; PRIMARY TUMOR; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK ASSESSMENT; SEX; SURVIVAL PREDICTION; TUMOR INVASION; TUMOR ULCERATION; TUMOR VOLUME;

LYMPH NODE; LYMPH NODE DISSECTION; MELANOMA; PROGNOSIS;

ADULT; AGED; FEMALE; HUMANS; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; MALE; MELANOMA; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; SKIN NEOPLASMS; TREATMENT OUTCOME; TUMOR BURDEN;

EID: 84904675632     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mdt510     Document Type: Article

References (23)

1. Balch CM, Gershenwald JE, Soong SJ et al. Multivariate analysis of prognostic factors among 2,313 patients with stage III melanoma: comparison of nodal micrometastases versus macrometastases. J Clin Oncol 2010; 28: 2452-2459.
2. Lens MB, Dawes M, Goodacre T et al. Elective lymph node dissection in patients with melanoma: systematic review and meta-analysis of randomized controlled trials. Arch Surg 2002; 137: 458-461.
3. Morton DL, Thompson JF, Cochran AJ et al. Sentinel-node biopsy or nodal observation in melanoma. N Engl J Med 2006; 355: 1307-1317.
4. Pasquali S, Mocellin S, Campana LG et al. Early (sentinel lymph node biopsyguided) versus delayed lymphadenectomy in melanoma patients with lymph node metastases: personal experience and literature meta-analysis. Cancer 2010; 116: 1201-1209.
5. Morton DL. Overview and update of the phase III Multicenter Selective Lymphadenectomy Trials (MSLT-I and MSLT-II) in melanoma. Clin Exp Metastasis 2012; 29: 699-706.
6. Mocellin S, Pasquali S, Rossi CR et al. Validation of the prognostic value of lymph node ratio in patients with cutaneous melanoma: a population-based study of 8,177 cases. Surgery 2011; 150: 83-90.
7. Rossi CR, Mocellin S, Pasquali S et al. N-ratio: a novel independent prognostic factor for patients with stage-III cutaneous melanoma. Ann Surg Oncol 2008; 15: 310-315.
8. Spillane AJ, Cheung BL, Winstanley J et al. Lymph node ratio provides prognostic information in addition to American joint committee on cancer N stage in patients with melanoma, even if quality of surgery is standardized. Ann Surg 2011; 253: 109-115.
9. Xing Y, Badgwell BD, Ross MI et al. Lymph node ratio predicts disease-specific survival in melanoma patients. Cancer 2009; 115: 2505-2513.
10. Spillane AJ, Haydu L, McMillan W et al. Quality assurance parameters and predictors of outcome for ilioinguinal and inguinal dissection in a contemporary melanoma patient population. Ann Surg Oncol 2011; 18: 2521-2528.
11. van der Ploeg AP, van Akkooi AC, Schmitz PI et al. Therapeutic surgical management of palpable melanoma groin metastases: superficial or combined superficial and deep groin lymph node dissection. Ann Surg Oncol 2011; 18: 3300-3308.
12. Grotz TE, Huebner M, Pockaj BA et al. Limitations of lymph node ratio, evidencebased benchmarks, and the importance of a thorough lymph node dissection in melanoma. Ann Surg Oncol 2013 September 18 [epub ahead of print], doi: 10.1245/s10434-013-3186-0.
13. Chan AD, Essner R, Wanek LA et al. Judging the therapeutic value of lymph node dissections for melanoma. J Am Coll Surg 2000; 191: 16-22; discussion 22-13.
14. Galliot-Repkat C, Cailliod R, Trost O et al. The prognostic impact of the extent of lymph node dissection in patients with stage III melanoma. Eur J Surg Oncol 2006; 32: 790-794.
15. Wong SL. Lymph node evaluation in colon cancer: assessing the link between quality indicators and quality. JAMA 2011; 306: 1139-1141.
16. Cascinelli N, Bombardieri E, Bufalino R et al. Sentinel and nonsentinel node status in stage IB and II melanoma patients: two-step prognostic indicators of survival. J Clin Oncol 2006; 24: 4464-4471.
17. Gervasoni JE, Jr, Sbayi S, Cady B. Role of lymphadenectomy in surgical treatment of solid tumors: an update on the clinical data. Ann Surg Oncol 2007; 14: 2443-2462.
18. Balch CM, Gershenwald JE, Soong SJ et al. Final version of 2009 AJCC melanoma staging and classification. J Clin Oncol 2009; 27: 6199-6206.
19. Spillane AJ, Cheung BL, Stretch JR et al. Proposed quality standards for regional lymph node dissections in patients with melanoma. Ann Surg 2009; 249: 473-480.
20. Pasquali S, Spillane AJ, de Wilt JH et al. Surgeons' opinions on lymphadenectomy in melanoma patients with positive sentinel nodes: a worldwide web-based survey. Ann Surg Oncol 2012; 258: 152-157.
21. Spillane AJ, Pasquali S, Haydu LE et al. Patterns of recurrence and survival after lymphadenectomy in melanoma patients: clarifying the effects of timing of surgery and lymph node tumor burden. Ann Surg Oncol 2013 September 20 [epub ahead of print], doi: 10.1245/s10434-013-3253-6.
22. Mocellin S, Lens MB, Pasquali S et al. Interferon alpha for the adjuvant treatment of cutaneous melanoma. Cochrane Database Syst Rev 2013; 6: CD008955.
23. Burmeister BH, Henderson MA, Ainslie J et al. Adjuvant radiotherapy versus observation alone for patients at risk of lymph-node field relapse after therapeutic lymphadenectomy for melanoma: a randomised trial. Lancet Oncol 2012; 13: 589-597.